By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

The Voice of People With Breast Cancer

What breast cancer drugs are available in Canada

MedSearch

Search Database

Search our database using the keyword search and filters below.

The purpose of the breast cancer drug navigation tool is to help patients and caregivers easily find information about what breast cancer drugs are publicly funded in each province and territory across Canada, including their status within the drug approval process. This tool provides general information about the various treatments for breast cancer. It also directs patients to information about additional funding sources for drugs that aren’t currently listed on public formularies.

This is not meant to act as a treatment decision aid, but rather to provide general information about which breast cancer treatments are available in Canada, and how they are funded. All information obtained about specific treatments should be further discussed with your physician.

Note: If you search by province, you will only be given a list of the drugs that are PUBLICLY funded. To search for all treatment options that are Health Canada approved, leave the “Select A Region” field blank.


Search results

Generic Name Brand Name Breast cancer type Breast cancer stage Where in the drug approval process is this treatment
Atezolizumab Tecentriq Triple Negative Stage IV (metastatic) Health Canada - Approved
Capecitabine Xeloda; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Carboplatin various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Cisplatin various brand names HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Listed on Provincial Drug Formulary
Cyclophosphamide Procytox; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Docetaxel Taxotere; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Doxorubicin Adriamycin; Myocet; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Epirubicin Pharmorubicin; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Eribulin Halaven HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Listed on Provincial Drug Formulary
Fluorouracil Actikerall; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Gemcitabine Gemzar; various brand names HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Listed on Provincial Drug Formulary
Methotrexate Metoject; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Mitoxantrone various brand names HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Listed on Provincial Drug Formulary
Olaparib Lynparza HR+, HER2-, Triple Negative, BRCA Stage IV (metastatic) Health Canada - Approved
Olaparib Lynparza HR+, HER2-, Triple Negative, BRCA Stage 0, I, II, III Listed on Provincial Drug Formulary
Paclitaxel Taxol; various brand names HR+, HER2-, HER2+, Triple Negative Stage 0, I, II, III, Stage IV (metastatic) Listed on Provincial Drug Formulary
Paclitaxel-nab Abraxane HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Listed on Provincial Drug Formulary
Pegylated Liposomal Doxorubicin Caelyx HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Health Canada - Approved
Pembrolizumab Keytruda Triple Negative Stage IV (metastatic) PCPA - Approved; Provincial Review Ongoing
Pembrolizumab Keytruda Triple Negative Stage 0, I, II, III Listed on Provincial Drug Formulary
Sacituzumab govitecan Trodelvy Triple Negative Stage IV (metastatic) PCPA - Approved; Provincial Review Ongoing
Temozolomide Temodal; various brand names HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Listed on Provincial Drug Formulary
Vinorelbine various brand names HR+, HER2-, HER2+, Triple Negative Stage IV (metastatic) Listed on Provincial Drug Formulary

New Search

MedSearch Disclaimer

This tool is for informational and educational purposes only and is not meant to guide treatment decisions. All information and treatment decisions should be discussed with your physician. The content is not intended in any way to be a substitute for professional medical advice. This information is reviewed and updated on a quarterly basis or as new funding information becomes available. While we do our best to ensure that all content is current we cannot guarantee that changes have not been made to the public formularies without our knowledge. 

SHARE

FAQ’s

  • Generic vs. Brand Name

    What is the difference between a Generic drug and a Brand Name drug?

    Brand name, or innovator drugs are drugs that are researched, developed and marketed by a specific pharmaceutical company. After a pharmaceutical company researches and gains approval to develop a drug they apply for a patent, allowing them to exclusively produce and sell that drug.  Patents on drugs often have an expiration date. Once the patent runs out other pharmaceutical companies are free to produce and sell the drug as well. A generic drug is a copy of the original brand name drug and uses the same active ingredients but is simply being developed by another pharmaceutical company. Generic drug manufactures are required to follow the same manufacturing and safety standards as brand name manufactures.

    For more information about the difference between generic and brand name drugs, visit the Canadian Agency for Drugs and Technologies in Health (CADTH)

  • Provincial/Territorial Formularies

    What is the contact information for my provincial/territorial formulary?

    A list of formularies and their contact information is available HERE.

  • Income Support Programs

    Where do I find more information on income support programs to fund the cost of my drugs in my province/territory?

    Use our FinancialNavigator Database to find provincial and federal governmental income support programs and other avenues of financial support by searching “Income Supplement” and your province.

  • Manufacturer Patient Assistance Programs

    How do I contact the manufacturer to inquire about whether or not a portion of, or all of the costs of a drug is covered through their Patient Assistance Program?

    You can search for all available manufacturer Patient Assistances Programs and more avenues of support on our FinancialNavigator by searching “Drug Coverage”. You can also visit Drug Access Canada for more resources on accessing breast cancer drugs in Canada.

  • Drugs that aren’t covered on a formulary

    How do I access drugs that aren’t covered on a provincial/territorial formulary?

    Learn more about programs that may help cover drugs that aren’t listed on the public formularies HERE or by searching our FinancialNavigator Database.  

    What is the Trillium Drug Program in Ontario, am I eligible and how do I apply?

    Read this Q & A fact sheet for more information on this program and how it can potentially help offset the costs of your take home cancer medications.

  • Private Insurance

    How can my private insurance help pay for drugs that aren’t covered through public funding?

    Find more information about private insurance HERE.

  • Drug approval process in Canada

    Where do I find more information about the drug approval process in Canada?

    Learn more about the drug approval process in Canada HERE.

  • Clinical Trials

    Where do I find more information about clinical trials in Canada?

    Learn more about metastatic breast cancer clinical trials in Canada HERE

  • Cancer Centres in Canada

    Where do I find a list of cancer centres and contact information?

    A list of cancer centres in Canada and their contact information is HERE.

  • Additional Information

    I have information to help update this tool, who do I contact?

    If you have additional information that would be helpful to include in this tool please email cbcn@cbcn.ca or call us at 1-800-685-8820.

  • Contacting CBCN

    How can I connect with CBCN directly about specific questions?

    Connect with us via email at cbcn@cbcn.ca or on the phone at 1-800-685-8820.